Global Non-Invasive Prenatal Testing (NIPT) Market Research Report 2021
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Non-Invasive Prenatal Testing (NIPT) Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Non-Invasive Prenatal Testing (NIPT) Market Overview:
Global Non-Invasive Prenatal Testing (NIPT) Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Non-Invasive Prenatal Testing (NIPT) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Non-Invasive Prenatal Testing (NIPT) Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Non-Invasive Prenatal Testing (NIPT) market in 2020.
Global Non-Invasive Prenatal Testing (NIPT) Market Segmentation
By Type, Non-Invasive Prenatal Testing (NIPT) market has been segmented into:
Ultrasound Detection
Biochemical Screening Tests
Cell-Free Dna In Maternal Plasma Tests
Fetal Cells In Maternal Blood Tests
Others
By Application, Non-Invasive Prenatal Testing (NIPT) market has been segmented into:
Hospitals
Clinics
Research Laboratories
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Non-Invasive Prenatal Testing (NIPT) market are:
GE Healthcare
Koninklijke Philips
BGI Genomics
Illumina
Thermo Fisher Scientific
F. Hoffmann-La Roche
Pacific Biosciences Of California
Perkinelmer
Qiagen
Agilent Technologies
LifeCodexx
Berry Genomics
LifeLabs Genetics
Quest Diagnostics
Safembryo
Laboratory Corporation of America Holdings
Natera
Sequenom
Ariosa Diagnostics
CombiMatrix
1. Market Overview of Non-Invasive Prenatal Testing (NIPT)
1.1 Non-Invasive Prenatal Testing (NIPT) Market Overview
1.1.1 Non-Invasive Prenatal Testing (NIPT) Product Scope
1.1.2 Market Status and Outlook
1.2 Non-Invasive Prenatal Testing (NIPT) Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Non-Invasive Prenatal Testing (NIPT) Historic Market Size by Regions (2015-2020)
1.4 Non-Invasive Prenatal Testing (NIPT) Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Non-Invasive Prenatal Testing (NIPT) Sales Market by Type (2015-2026)
2.1 Global Non-Invasive Prenatal Testing (NIPT) Historic Market Size by Type (2015-2020)
2.2 Global Non-Invasive Prenatal Testing (NIPT) Forecasted Market Size by Type (2021-2026)
2.3 Ultrasound Detection
2.4 Biochemical Screening Tests
2.5 Cell-Free Dna In Maternal Plasma Tests
2.6 Fetal Cells In Maternal Blood Tests
2.7 Others
3. Covid-19 Impact Non-Invasive Prenatal Testing (NIPT) Sales Market by Application (2015-2026)
3.1 Global Non-Invasive Prenatal Testing (NIPT) Historic Market Size by Application (2015-2020)
3.2 Global Non-Invasive Prenatal Testing (NIPT) Forecasted Market Size by Application (2021-2026)
3.3 Hospitals
3.4 Clinics
3.5 Research Laboratories
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Non-Invasive Prenatal Testing (NIPT) Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Non-Invasive Prenatal Testing (NIPT) Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Non-Invasive Prenatal Testing (NIPT) Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Non-Invasive Prenatal Testing (NIPT) Business
5.1 GE Healthcare
5.1.1 GE Healthcare Company Profile
5.1.2 GE Healthcare Non-Invasive Prenatal Testing (NIPT) Product Specification
5.1.3 GE Healthcare Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 Koninklijke Philips
5.2.1 Koninklijke Philips Company Profile
5.2.2 Koninklijke Philips Non-Invasive Prenatal Testing (NIPT) Product Specification
5.2.3 Koninklijke Philips Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 BGI Genomics
5.3.1 BGI Genomics Company Profile
5.3.2 BGI Genomics Non-Invasive Prenatal Testing (NIPT) Product Specification
5.3.3 BGI Genomics Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Illumina
5.4.1 Illumina Company Profile
5.4.2 Illumina Non-Invasive Prenatal Testing (NIPT) Product Specification
5.4.3 Illumina Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 Thermo Fisher Scientific
5.5.1 Thermo Fisher Scientific Company Profile
5.5.2 Thermo Fisher Scientific Non-Invasive Prenatal Testing (NIPT) Product Specification
5.5.3 Thermo Fisher Scientific Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 F. Hoffmann-La Roche
5.6.1 F. Hoffmann-La Roche Company Profile
5.6.2 F. Hoffmann-La Roche Non-Invasive Prenatal Testing (NIPT) Product Specification
5.6.3 F. Hoffmann-La Roche Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Pacific Biosciences Of California
5.7.1 Pacific Biosciences Of California Company Profile
5.7.2 Pacific Biosciences Of California Non-Invasive Prenatal Testing (NIPT) Product Specification
5.7.3 Pacific Biosciences Of California Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.8 Perkinelmer
5.8.1 Perkinelmer Company Profile
5.8.2 Perkinelmer Non-Invasive Prenatal Testing (NIPT) Product Specification
5.8.3 Perkinelmer Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.9 Qiagen
5.9.1 Qiagen Company Profile
5.9.2 Qiagen Non-Invasive Prenatal Testing (NIPT) Product Specification
5.9.3 Qiagen Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.10 Agilent Technologies
5.10.1 Agilent Technologies Company Profile
5.10.2 Agilent Technologies Non-Invasive Prenatal Testing (NIPT) Product Specification
5.10.3 Agilent Technologies Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.11 LifeCodexx
5.11.1 LifeCodexx Company Profile
5.11.2 LifeCodexx Non-Invasive Prenatal Testing (NIPT) Product Specification
5.11.3 LifeCodexx Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.12 Berry Genomics
5.12.1 Berry Genomics Company Profile
5.12.2 Berry Genomics Non-Invasive Prenatal Testing (NIPT) Product Specification
5.12.3 Berry Genomics Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.13 LifeLabs Genetics
5.13.1 LifeLabs Genetics Company Profile
5.13.2 LifeLabs Genetics Non-Invasive Prenatal Testing (NIPT) Product Specification
5.13.3 LifeLabs Genetics Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.14 Quest Diagnostics
5.14.1 Quest Diagnostics Company Profile
5.14.2 Quest Diagnostics Non-Invasive Prenatal Testing (NIPT) Product Specification
5.14.3 Quest Diagnostics Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.15 Safembryo
5.15.1 Safembryo Company Profile
5.15.2 Safembryo Non-Invasive Prenatal Testing (NIPT) Product Specification
5.15.3 Safembryo Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.16 Laboratory Corporation of America Holdings
5.16.1 Laboratory Corporation of America Holdings Company Profile
5.16.2 Laboratory Corporation of America Holdings Non-Invasive Prenatal Testing (NIPT) Product Specification
5.16.3 Laboratory Corporation of America Holdings Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.17 Natera
5.17.1 Natera Company Profile
5.17.2 Natera Non-Invasive Prenatal Testing (NIPT) Product Specification
5.17.3 Natera Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.18 Sequenom
5.18.1 Sequenom Company Profile
5.18.2 Sequenom Non-Invasive Prenatal Testing (NIPT) Product Specification
5.18.3 Sequenom Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.19 Ariosa Diagnostics
5.19.1 Ariosa Diagnostics Company Profile
5.19.2 Ariosa Diagnostics Non-Invasive Prenatal Testing (NIPT) Product Specification
5.19.3 Ariosa Diagnostics Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.20 CombiMatrix
5.20.1 CombiMatrix Company Profile
5.20.2 CombiMatrix Non-Invasive Prenatal Testing (NIPT) Product Specification
5.20.3 CombiMatrix Non-Invasive Prenatal Testing (NIPT) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Non-Invasive Prenatal Testing (NIPT) Market Size (2015-2026)
6.2 North America Non-Invasive Prenatal Testing (NIPT) Key Players in North America (2015-2020)
6.3 North America Non-Invasive Prenatal Testing (NIPT) Market Size by Type (2015-2020)
6.4 North America Non-Invasive Prenatal Testing (NIPT) Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Non-Invasive Prenatal Testing (NIPT) Market Size (2015-2026)
7.2 East Asia Non-Invasive Prenatal Testing (NIPT) Key Players in North America (2015-2020)
7.3 East Asia Non-Invasive Prenatal Testing (NIPT) Market Size by Type (2015-2020)
7.4 East Asia Non-Invasive Prenatal Testing (NIPT) Market Size by Application (2015-2020)
8. Europe
8.1 Europe Non-Invasive Prenatal Testing (NIPT) Market Size (2015-2026)
8.2 Europe Non-Invasive Prenatal Testing (NIPT) Key Players in North America (2015-2020)
8.3 Europe Non-Invasive Prenatal Testing (NIPT) Market Size by Type (2015-2020)
8.4 Europe Non-Invasive Prenatal Testing (NIPT) Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Non-Invasive Prenatal Testing (NIPT) Market Size (2015-2026)
9.2 South Asia Non-Invasive Prenatal Testing (NIPT) Key Players in North America (2015-2020)
9.3 South Asia Non-Invasive Prenatal Testing (NIPT) Market Size by Type (2015-2020)
9.4 South Asia Non-Invasive Prenatal Testing (NIPT) Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Non-Invasive Prenatal Testing (NIPT) Market Size (2015-2026)
10.2 Southeast Asia Non-Invasive Prenatal Testing (NIPT) Key Players in North America (2015-2020)
10.3 Southeast Asia Non-Invasive Prenatal Testing (NIPT) Market Size by Type (2015-2020)
10.4 Southeast Asia Non-Invasive Prenatal Testing (NIPT) Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Non-Invasive Prenatal Testing (NIPT) Market Size (2015-2026)
11.2 Middle East Non-Invasive Prenatal Testing (NIPT) Key Players in North America (2015-2020)
11.3 Middle East Non-Invasive Prenatal Testing (NIPT) Market Size by Type (2015-2020)
11.4 Middle East Non-Invasive Prenatal Testing (NIPT) Market Size by Application (2015-2020)
12. Africa
12.1 Africa Non-Invasive Prenatal Testing (NIPT) Market Size (2015-2026)
12.2 Africa Non-Invasive Prenatal Testing (NIPT) Key Players in North America (2015-2020)
12.3 Africa Non-Invasive Prenatal Testing (NIPT) Market Size by Type (2015-2020)
12.4 Africa Non-Invasive Prenatal Testing (NIPT) Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Non-Invasive Prenatal Testing (NIPT) Market Size (2015-2026)
13.2 Oceania Non-Invasive Prenatal Testing (NIPT) Key Players in North America (2015-2020)
13.3 Oceania Non-Invasive Prenatal Testing (NIPT) Market Size by Type (2015-2020)
13.4 Oceania Non-Invasive Prenatal Testing (NIPT) Market Size by Application (2015-2020)
14. South America
14.1 South America Non-Invasive Prenatal Testing (NIPT) Market Size (2015-2026)
14.2 South America Non-Invasive Prenatal Testing (NIPT) Key Players in North America (2015-2020)
14.3 South America Non-Invasive Prenatal Testing (NIPT) Market Size by Type (2015-2020)
14.4 South America Non-Invasive Prenatal Testing (NIPT) Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Non-Invasive Prenatal Testing (NIPT) Market Size (2015-2026)
15.2 Rest of the World Non-Invasive Prenatal Testing (NIPT) Key Players in North America (2015-2020)
15.3 Rest of the World Non-Invasive Prenatal Testing (NIPT) Market Size by Type (2015-2020)
15.4 Rest of the World Non-Invasive Prenatal Testing (NIPT) Market Size by Application (2015-2020)
16 Non-Invasive Prenatal Testing (NIPT) Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Non Invasive Prenatal Testing (NIPT) Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|